June 27, 2017 | Omar Perez of Pfizer is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit, which runs August 15th to the 18th in Washington, DC. Topics include using key commercialization challenges for precision medicine or companion diagnostics, starting the discussion between a diagnostic and a pharmaceutical company regarding co-commercialization, and more. Here is a sample of the discussion that takes place. Podcast
CHI: What are the key commercialization challenges for precision medicine or companion diagnostics?
Omar Perez: Well, I would say there's a number of challenges for a global company that has to commercialize products around the world. We definitely have to keep in mind all the various regulatory requirements that are region specific, as well as who ends up paying for the test that ends up select the patients for our products. The challenges are vast and great and they vary by country-to-country, but essentially it's how do we get the product out to market, who has to pay for it, and how does it support our patient identification strategies.